Search

Your search keyword '"Kanto T."' showing total 332 results

Search Constraints

Start Over You searched for: Author "Kanto T." Remove constraint Author: "Kanto T."
332 results on '"Kanto T."'

Search Results

2. Renewable hydrogen storage and supply options for large-scale industrial users in Finland

4. The case for simplifying and using absolute targets for viral hepatitis elimination goals

5. Risk factors for hepatocellular carcinoma in hepatitis C patients with normal alanine aminotransferase treated with pegylated interferon and ribavirin

6. Land-use vs. output of energy technologies in Finland

8. Factors affecting efficacy in patients with genotype 2 chronic hepatitis C treated by pegylated interferon alpha-2b and ribavirin: reducing drug doses has no impact on rapid and sustained virological responses

10. Pegylated interferon alpha-2b (Peg-IFN α-2b) affects early virologic response dose-dependently in patients with chronic hepatitis C genotype 1 during treatment with Peg-IFN α-2b plus ribavirin

11. Ribavirin dose reduction raises relapse rate dose-dependently in genotype 1 patients with hepatitis C responding to pegylated interferon alpha-2b plus ribavirin

19. Activated Fibroblasts Recovered from the Cirrhotic Liver Provide Malignancy-Prone Phenotypes to Cancer Cells and Macrophages: Comparable Capacity with Cancer-Associated Fibroblasts in Hepatocellular Carcinoma

24. P757 REDUCING POLYMORPHISMS CONSISTING OF (TA)N DINUCLEOTIDE REPEAT NEAR IL28B GENE ASSOCIATE WITH THE DEVIATION OF IL28B SNPS AND AFFECT VIRAL RESPONSE OF PEGIFN/RBV

26. P758 ASSOCIATION OF LIVER DISEASES-RELATED SINGLE NUCLEOTIDE POLYMORPHISMS ON DEVELOPMENT OF HEPATOCELLULAR CARCINOMA IN JAPANESE PATIENTS WITH HEPATITIS C VIRUS

29. Risk factors for hepatocellular carcinoma in hepatitis C patients with normal alanine aminotransferase treated with pegylated interferon and ribavirin

30. Mcl-1 and Bcl-xL regulate Bak/Bax-dependent apoptosis of the megakaryocytic lineage at multistages

31. 333 THE USEFULLNESS OF VS/PLT: A NEW MARKER OF LIVER FIBROSIS

35. Impaired ability of interferon‐alpha‐primed dendritic cells to stimulate Th1‐type CD4 T‐cell response in chronic hepatitis C virus infection

48. Dynamics of regulatory T cells and plasmacytoid dendritic cells as immune markers for virological response in pegylated interferon-α and ribavirin therapy for chronic hepatitis C patients.

49. Differential alteration of CD56(bright) and CD56 (dim) natural killer cells in frequency, phenotype, and cytokine response in chronic hepatitis C virus infection.

Catalog

Books, media, physical & digital resources